AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2026)

AdaptHealth has reported Current Deferred Revenue for 9 years, with the latest figure at $59.7 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 28.59% year-over-year to $59.7 million; the trailing twelve-month figure through Mar 2026 stood at $59.7 million (up 28.59% YoY), and the FY2025 full-year result was $59.8 million, up 71.25% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $59.7 million, roughly flat from $59.8 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $59.9 million in Q3 2025, with the low at $30.6 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $41.3 million, with a median of $35.8 million recorded in 2024.
• Year-over-year, Current Deferred Revenue retreated 25.3% in 2024 and surged 71.25% in 2025.
• Tracing AHCO's Current Deferred Revenue over 5 years: stood at $31.6 million in 2022, then rose by 21.9% to $38.6 million in 2023, then retreated by 9.4% to $34.9 million in 2024, then surged by 71.25% to $59.8 million in 2025, then fell by 0.19% to $59.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $59.7 million (Q1 2026), $59.8 million (Q4 2025), and $59.9 million (Q3 2025), per Business Quant data.

Peer Comparison